Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04069650
Other study ID # ZWETYENGA 2018
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2018
Est. completion date June 30, 2018

Study information

Verified date August 2019
Source Centre Hospitalier Universitaire Dijon
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Free flap reconstruction consists in replacing tissular defect from one body part by another tissu harvested in a distant site. Microsurgery has to be performed to restore vascularization.

Free flaps are now the gold standard in complex reconstruction. While reliable with a success rate superior to 95 %, a failure takes a heavy burden on the patient. Many risk factors have been highlitghted in free flap failure for head and neck microvascular reconstruction.

Among them, malnutrition is still debated. This is a retrospective cohort study comparing complications occurrence between two groups. One group with normal nutritionnal status, the other with malnutrition. Between january 2008 and january 2018, 70 patients who underwent oral cavity reconstruction using free flap were included. This is the first study known to date which uses clinical and biological variables to determine the nutritionnal status.

Malnutrition is not associated with a higher risk for free flap failure in the oral cavity.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date June 30, 2018
Est. primary completion date May 31, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- every consenting patients undergoing free flap reconstruction of the oral cavity

Exclusion Criteria:

- unable to give consent

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Free flap
Free flap reconstruction of the oral cavity

Locations

Country Name City State
France Chu Dijon Bourgogne Dijon

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Major complication occurency in the first-month post-operative period, complications leading to flap loss 1 month
Secondary Minor complication occurency in the first-month post-operative period, complications NOT leading to flap loss 1 month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03118076 - The Effect of Dexmedetomidine as an Adjuvant for Lower Limb Nerve Blocks Phase 4